Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
RFNG - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
TBC1D13 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GALNS - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NARFL - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TNIP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SH3BGRL3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RTEL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ECI1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMED3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MAN2B1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MROH1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
STRA13 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PLA2G6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BICDL2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MED16 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CD81 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CPT1A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RNF187 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on